Basel Medical Group Ltd (BMGL)
NASDAQ: BMGL · Real-Time Price · USD
0.623
+0.013 (2.13%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Basel Medical Group Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022
Period Ending
Apr '26 Jun '25 Jun '24 Jun '23 Jun '22
Market Capitalization
1233---
Enterprise Value
929---
Last Close Price
0.621.78---
PS Ratio
1.313.75---
PB Ratio
2.747.83---
P/TBV Ratio
2.747.84---
EV/Sales Ratio
1.023.30---
Debt / Equity Ratio
1.201.200.761.312.74
Debt / EBITDA Ratio
--2.102.823.34
Debt / FCF Ratio
--2.282.783.76
Net Debt / Equity Ratio
-0.60-0.600.491.082.29
Net Debt / EBITDA Ratio
1.621.621.652.903.42
Net Debt / FCF Ratio
0.220.221.472.273.14
Asset Turnover
0.650.650.630.61-
Inventory Turnover
31.9031.9070.6667.92-
Quick Ratio
1.221.220.550.630.63
Current Ratio
1.311.312.262.282.18
Return on Equity (ROE)
-163.64%-163.64%31.77%38.79%-
Return on Assets (ROA)
-7.65%-7.65%8.66%7.77%-
Return on Invested Capital (ROIC)
-99.61%-32.00%16.73%14.21%16.72%
Return on Capital Employed (ROCE)
-25.10%-25.10%24.00%22.50%25.50%
Earnings Yield
-71.37%-24.98%---
FCF Yield
-99.95%-35.09%---
Buyback Yield / Dilution
-15.60%-15.60%---
Source: S&P Capital IQ. Standard template. Financial Sources.